All lobbying filings

Arentfox Schiff LLP

Arentfox Schiff LLP filed a Q2 report for Organogenesis Inc. on July 21, 2025, reporting $20,000 in lobbying income.

Lobbying for Organogenesis Inc. · Biotech company

As filed: ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

All filings by Arentfox Schiff LLP · Everything Organogenesis Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products

Health Issues

Food and Drug Administration policy on chronic wound healing products

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.